Synthesis and structure-activity relationships of 3,4,5-trisubstituted-1,2,4-triazoles: high affinity and selective somatostatin receptor-4 agonists for Alzheimer's disease treatment.
Journal
RSC medicinal chemistry
ISSN: 2632-8682
Titre abrégé: RSC Med Chem
Pays: England
ID NLM: 101759460
Informations de publication
Date de publication:
18 Aug 2021
18 Aug 2021
Historique:
received:
11
02
2021
accepted:
14
04
2021
entrez:
30
8
2021
pubmed:
31
8
2021
medline:
31
8
2021
Statut:
epublish
Résumé
Somatostatin receptor-4 (SST
Identifiants
pubmed: 34458738
doi: 10.1039/d1md00044f
pii: d1md00044f
pmc: PMC8372316
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1352-1365Subventions
Organisme : NIA NIH HHS
ID : R01 AG047858
Pays : United States
Informations de copyright
This journal is © The Royal Society of Chemistry.
Déclaration de conflit d'intérêts
The authors declared the following conflict of interests: Drs. Neumann, Sandoval, Kontoyianni, Hospital, Crider, and Witt are co-inventors on patent applications for the development of SST4 agonists, through Southern Illinois University Edwardsville (USA patent application No. PCT/US2018/032368; European National Application No. 18798793.8, Japanese Application No. 2019-562574). Ken Witt is CEO of Somatolynk Inc., a company focused on advancement of SST4 agonists.
Références
Arch Int Pharmacodyn Ther. 1990 May-Jun;305:140-51
pubmed: 2241425
Front Neural Circuits. 2016 Jun 30;10:48
pubmed: 27445703
Front Neuroendocrinol. 1999 Jul;20(3):157-98
pubmed: 10433861
Nature. 1980 Nov 20;288(5788):279-80
pubmed: 6107862
Mol Cell Endocrinol. 2008 May 14;286(1-2):75-87
pubmed: 17997029
Nature. 2012 Dec 13;492(7428):215-20
pubmed: 23235874
DNA Cell Biol. 1995 Nov;14(11):939-44
pubmed: 7576180
Biochim Biophys Acta. 2003 Sep 22;1616(1):1-84
pubmed: 14507421
Neuroscience. 2000;98(3):523-33
pubmed: 10869846
Eur J Pharmacol. 2012 May 15;683(1-3):116-24
pubmed: 22449380
J Physiol. 2006 Apr 15;572(Pt 2):477-92
pubmed: 16469784
J Neurosci. 2000 May 15;20(10):3785-97
pubmed: 10804219
Chem Res Toxicol. 1997 Jul;10(7):733-41
pubmed: 9250406
Neurosci Lett. 2003 Oct 23;350(2):113-6
pubmed: 12972166
J Med Chem. 2010 Jul 22;53(14):5061-84
pubmed: 20345171
J Med Chem. 1998 Nov 19;41(24):4693-705
pubmed: 9822540
Neuropeptides. 1983 Apr;3(4):263-70
pubmed: 6135174
Brain Res. 1987 Feb 17;403(2):234-42
pubmed: 3828820
Nat Med. 2005 Apr;11(4):434-9
pubmed: 15778722
J Chem Inf Model. 2012 Jan 23;52(1):171-86
pubmed: 22148589
Neurochem Res. 2009 Apr;34(4):660-9
pubmed: 19247832
Science. 2019 Aug 9;365(6453):559-565
pubmed: 31395777
Brain Res. 2013 Jul 3;1520:145-56
pubmed: 23669069
J Med Chem. 2003 Jun 5;46(12):2334-44
pubmed: 12773038
J Alzheimers Dis. 2019;68(4):1699-1710
pubmed: 30958364
Neuropeptides. 1988 Nov-Dec;12(4):237-42
pubmed: 2907122
Front Endocrinol (Lausanne). 2018 Feb 27;9:55
pubmed: 29535682
EMBO Mol Med. 2016 Jun 01;8(6):595-608
pubmed: 27025652
Eur J Pharmacol. 2006 Jun 6;539(1-2):71-5
pubmed: 16697366
Medchemcomm. 2018 Nov 7;9(12):2083-2090
pubmed: 30746066
Neurobiol Dis. 2006 Dec;24(3):475-83
pubmed: 17008108
Brain Res Bull. 2018 Jul;141:20-26
pubmed: 29174732
Behav Brain Res. 2008 Sep 1;192(1):106-13
pubmed: 18359102
Eur J Pharmacol. 2011 Mar 1;654(1):53-9
pubmed: 21185826
Nitric Oxide. 2017 May 1;65:10-21
pubmed: 28137611
Mol Cell Endocrinol. 2008 May 14;286(1-2):96-103
pubmed: 18221832
Prog Neurobiol. 2009 Oct;89(2):153-61
pubmed: 19595735
J Alzheimers Dis. 2017;59(3):913-927
pubmed: 28697571
Nature. 2006 Mar 16;440(7082):352-7
pubmed: 16541076
Neuroscience. 2017 Mar 27;346:320-336
pubmed: 28161436
Psychopharmacology (Berl). 2009 Jan;202(1-3):153-63
pubmed: 18521573
Int J Mol Sci. 2019 Jun 17;20(12):
pubmed: 31212931
J Neurosci. 2008 Apr 2;28(14):3567-76
pubmed: 18385315
Brain Res. 2007 Jun 4;1152:191-200
pubmed: 17459354
Proc Natl Acad Sci U S A. 1980 Jul;77(7):3947-51
pubmed: 6254004
Curr Pharm Des. 2012;18(8):1123-30
pubmed: 22288401
J Neurosci. 2016 Sep 14;36(37):9647-58
pubmed: 27629715
Neuropharmacology. 2016 Feb;101:204-15
pubmed: 26387439
Pharmacol Ther. 2005 Nov;108(2):129-48
pubmed: 16112736
J Physiol Paris. 2000 May-Aug;94(3-4):211-5
pubmed: 11087999
Neurobiol Aging. 2019 Apr;76:18-23
pubmed: 30616208
J Biol Chem. 2006 Jun 30;281(26):17941-51
pubmed: 16636059
Physiol Behav. 2002 Aug;76(4-5):531-8
pubmed: 12126989
Neurochem Res. 2019 Nov;44(11):2670-2680
pubmed: 31630317
Nat Rev Drug Discov. 2017 Dec;16(12):829-842
pubmed: 29075003
J Drug Target. 1998;6(2):151-65
pubmed: 9886238
Eur J Pharmacol. 1988 Jul 14;151(3):399-407
pubmed: 2905659
J Neurochem. 2012 Jan;120 Suppl 1:125-139
pubmed: 22121920
Pharmacol Rev. 2018 Oct;70(4):763-835
pubmed: 30232095
J Alzheimers Dis. 2016 Oct 18;54(4):1339-1348
pubmed: 27589526
Neuropsychopharmacology. 2017 Jul;42(8):1647-1656
pubmed: 27986975
Rev Neurosci. 2003;14(3):285-301
pubmed: 14513869
Front Endocrinol (Lausanne). 2012 Dec 06;3:154
pubmed: 23230430
Brain Res. 2000 Jul 28;872(1-2):242-9
pubmed: 10924702